Naomi Hamburg, MD, is an Associate Professor of Medicine at Boston University School of Medicine. She is a clinical scientist with a translational research program focused on understanding the development of vascular complications in diabetes and peripheral artery disease. Her laboratory currently has three main areas of research. The first is characterizing insulin signaling resistance in the endothelium of patients with diabetes to develop novel theories to restore vascular function. The second is investigating new approaches to predicting clinical outcomes in patients with peripheral artery disease including biomarkers, microRNA and endogenous inhibitors of angiogenesis. The third is studying vascular function in community-based studies at the Framingham heart study.